期刊
PHYSICAL CHEMISTRY CHEMICAL PHYSICS
卷 23, 期 2, 页码 1197-1214出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0cp03620j
关键词
-
资金
- Pacific Northwest National Laboratory (PNNL) Laboratory Directed Research and Development program
- DOE [DE-AC05-76RL01830]
Non-competitive antagonists of the NMDAR have therapeutic benefits for neurological diseases, but can also lead to dissociative effects and the synthesis of illicit drugs. Generative deep learning models can help expand chemical space for drug exploration, but synthesis and experimental validation of generated compounds are still necessary.
Uncompetitive antagonists of the N-methyl d-aspartate receptor (NMDAR) have demonstrated therapeutic benefit in the treatment of neurological diseases such as Parkinson's and Alzheimer's, but some also cause dissociative effects that have led to the synthesis of illicit drugs. The ability to generate NMDAR antagonists in silico is therefore desirable for both new medication development and preempting and identifying new designer drugs. Recently, generative deep learning models have been applied to de novo drug design as a means to expand the amount of chemical space that can be explored for potential drug-like compounds. In this study, we assess the application of a generative model to the NMDAR to achieve two primary objectives: (i) the creation and release of a comprehensive library of experimentally validated NMDAR phencyclidine (PCP) site antagonists to assist the drug discovery community and (ii) an analysis of both the advantages conferred by applying such generative artificial intelligence models to drug design and the current limitations of the approach. We apply, and provide source code for, a variety of ligand- and structure-based assessment techniques used in standard drug discovery analyses to the deep learning-generated compounds. We present twelve candidate antagonists that are not available in existing chemical databases to provide an example of what this type of workflow can achieve, though synthesis and experimental validation of these compounds are still required.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据